Caladrius SEC Filing | Lisata Therapeutics, Inc.

Filing date	Form	Description	View
Mar 19, 2021	8-K	Report of unscheduled material events or corporate event	View HTML 0000320017-21-000046.pdf 0000320017-21-000046.rtf 0000320017-21-000046.xls
Feb 25, 2021	8-K	Report of unscheduled material events or corporate event	View HTML 0000320017-21-000042.pdf 0000320017-21-000042.rtf 0000320017-21-000042.xls
Feb 25, 2021	10-K	Annual report which provides a comprehensive overview of the company for the past year	View HTML 0000320017-21-000043.pdf 0000320017-21-000043.rtf 0000320017-21-000043.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Feb 24, 2021	SC 13G	A statement of beneficial ownership of common stock by certain persons	View HTML 0001104659-21-027247.pdf 0001104659-21-027247.rtf 0001104659-21-027247.xls
Feb 22, 2021	SC 13G	A statement of beneficial ownership of common stock by certain persons	View HTML 0001213900-21-010722.pdf 0001213900-21-010722.rtf 0001213900-21-010722.xls
Feb 22, 2021	SC 13G	A statement of beneficial ownership of common stock by certain persons	View HTML 0001567619-21-004569.pdf 0001567619-21-004569.rtf
Feb 18, 2021	SC 13G	A statement of beneficial ownership of common stock by certain persons	View HTML 0000902664-21-001481.pdf 0000902664-21-001481.rtf 0000902664-21-001481.xls
Feb 16, 2021	SC 13G/A	An amendment to the SC 13G filing	View HTML 0000919574-21-001509.pdf 0000919574-21-001509.rtf 0000919574-21-001509.xls
Feb 16, 2021	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	View HTML 0000320017-21-000030.pdf 0000320017-21-000030.rtf 0000320017-21-000030.xls
Feb 16, 2021	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	View HTML 0000320017-21-000028.pdf 0000320017-21-000028.rtf 0000320017-21-000028.xls